Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @AJMC_Journal: The @US_FDA is working to modernize the clinical trial process in order to answer the right questions about today’s… https://t.co/2HlJjkeHQY
SteveFDA (R-D.C.)
@SGottliebFDA
Medication-assisted treatment provides safe/controlled levels of medication to treat opioid use disorder. At proper doses, research has shown that MAT has no adverse effects on a person’s intelligence, mental capability, physical functioning or employabil
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA appreciates our collaboration with reputable Internet firms to address online sales of illicit opioids. We’re redirecting regulatory and criminal investigative resources to cracking down on these sales as parting our overall effort to combat addictio
SteveFDA (R-D.C.)
@SGottliebFDA
The dedication and expertise of #FDA’s workforce is the strength of this agency and we are committed to supporting our people. We are proud to show progress on implementation of the HR Cures and encourage you to read our report recapping these advances. #
SteveFDA (R-D.C.)
@SGottliebFDA
Today @US_FDA issued a small entity compliance guide to help animal drug manufacturers meet antimicrobial sales data reporting requirements. https://t.co/BAPgIE74HC
SteveFDA (R-D.C.)
@SGottliebFDA
Read #FDA’s new report on how our agency is continuing to deliver on its new Cures Act authorities to recruit, retain outstanding and highly qualified professionals. #FDAJobs: https://t.co/L4JJxSIpXf
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is also committed to improving recruitment, retention beyond HR Cures authorities with a new hiring pilot to streamline processes, reduce time to recruiting and onboarding new hires, a new Scientific Staffing team, and recruitment branding campaign h
SteveFDA (R-D.C.)
@SGottliebFDA
We updated our professsional staff today on our implementation of new authorities provided via 21st Century Cures Act that allows #FDA to better build, maintain our highly talented workforce needed to meet the challenges of today's rapid advances in scien
SteveFDA (R-D.C.)
@SGottliebFDA
Sales and distribution information are one piece of the overall picture related to antimicrobial resistance that help to better our understanding of this critical public health issue.
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is committed to working with federal, academic and industry partners to obtain more information about how, when and why animal producers and veterinarians use medically important antimicrobial drugs, and how this use can contribute to antimicrobial r
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is proud to play a role in supporting @TheJusticeDept #healthcarefraud actions today. Thank you to #FDA OCI and our law enforcement partners for taking action against those who prescribe unnecessary opioids and compounded meds for personal gain https
SteveFDA (R-D.C.)
@SGottliebFDA
In the coming months, FDA intends to announce our plan to improve the information available about compounded topical pain creams, which will help inform the medical community’s decisions about these products https://t.co/HOqBGN3BL5
SteveFDA (R-D.C.)
@SGottliebFDA
Federal officials have declared the E. coli outbreak linked to romaine lettuce over today. #FDA will continue its investigation to follow up on new leads we’ve identified related to how this lettuce got contaminated. https://t.co/UeCg1A4lK6
SteveFDA (R-D.C.)
@SGottliebFDA
Yesterday, #FDA hosted a variety of internet stakeholders to discuss the illegal sale of opioids online. Today I’m providing a recap of that meeting and next steps. Our work with internet stakeholders to combat this problem is just beginning. https://t.co
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is aware of pharmacies that compound topical pain creams comprised of multiple ingredients, some that are FDA-approved and some that are not. Drs and patients may not be aware of potential safety risks or potential lack of effectiveness associated wi
SteveFDA (R-D.C.)
@SGottliebFDA
My statement today on developments in the romaine outbreak investigation, updates on recent outbreaks, and #FDA’s increasing use of modern tools to advance food safety: https://t.co/3uIBB0M6gn https://t.co/ecTVlAdpxl
SteveFDA (R-D.C.)
@SGottliebFDA
The #FDA food lab is working to get the DNA fingerprint of the field samples and we will share more when it becomes available. https://t.co/UeCg1A4lK6
SteveFDA (R-D.C.)
@SGottliebFDA
The #FDA continues to strengthen the public health network that makes outbreak investigations more efficient and successful; and we’re dedicated to taking new steps to improve these capabilities to help keep families safe. https://t.co/3uIBB0M6gn https://
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA has also identified additional strains of E. coli in water and soil samples, but right now the samples do not match the outbreak strain. https://t.co/UeCg1A4lK6
SteveFDA (R-D.C.)
@SGottliebFDA
The federal-led team of investigators is conducting an environmental assessment and we’re tapping into technology that has shown us initial results from canal water in the Yuma area match the E. coli illness outbreak strain. https://t.co/UeCg1A4lK6